Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ACADIA Pharmaceuticals Inc.

TRADE

NASDAQ: ACADHealthcare / Biotechnology / USA
16.84-0.24-1.41%Vol 2 992 6731Y Perf -44.03%
Jul 20th, 2018 16:00
BID16.83 ASK16.84
Open17.11 Previous Close17.08
Pre-Market- After-Trading17.00
 - -%  0.16 0.95%
Target Price
50.25 
Analyst Rating
Strong Buy 1.00
Potencial %
198.40 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/50/-40 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-72/-96 
Growth Ranking
★★★ —    -
Insiders Shares Cnt. % 3/6/12M
-/-64/-94 
Income Ranking
 —    -
Market Cap (mil)2 102 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
8.73 
Earnings Date
14th Aug 2018

Today's Price Range

16.6117.41

 

52wk Range

14.5141.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
5.58%
3 Months
-15.38%
6 Months
-37.44%
1 Year
-44.03%
3 Years
-65.56%
5 Years
-15.88%

Quotes

Name / TickerPriceChg.Chg.%
ACAD16.84-0.2400-1.41
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.00
Current Ratio 7.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin94.30
EBIT Margin-163.10
EBITDA Margin-161.30
Pre-tax Profit Margin-70 240.70
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.17
PS Ratios 17.03
Price to Cash Flow -
Price to Free Cash Flow -16.30
Cash Flow Per Share -1.56
Price to Tangible Book7.29
Book Value per Share2.44
Enterprise Value (in ths.)1 881 400
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-61.00
ROE last 12 Months -61.38
Return on Assets (5Y Avg) -39.88
ROA last 12 Months -54.84
Return on Capital (5Y Avg) -54.80
ROC last 12 Months -67.18
Return on invested Capital Q -16.98
Return on invested Capital Y-67.80
Assets Turnover0.30
Receivables Turnover8.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)128 008
Revenue per Share 1.03
Revenue Growth 3 Years 1 287.32
Revenue Growth 5 Years 133.83
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.56-0.4421.43
Q04 2017-0.58-0.555.17
Q03 2017-0.63-0.5315.87
Q02 2017-0.71-0.5522.54
Q01 2017-0.73-0.721.37
Q04 2016-0.65-0.650.00
Q03 2016-0.55-0.61-10.91
Q02 2016-0.48-0.63-31.25
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.462.13Positive
9/2018 QR-0.382.56Positive
12/2018 FY-1.716.56Positive
12/2019 FY-0.5327.40Positive
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.44
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume2 992 673
Shares Outstanding (in ths.)124 830
Trades Count10 005
Dollar Volume47 802 889
Avg. Volume2 861 778
Avg. Weekly Volume2 651 279
Avg. Monthly Volume3 877 290
Avg. Quarterly Volume3 306 133

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

70%30%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x